` Comparison: HPR, PNEXF - Alpha Spread

H
HPR
vs
PNEXF

Over the past 12 months, HPR has underperformed PNEXF, delivering a return of 0% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
HPR
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

H
HPR Intrinsic Value
Not Available
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
H
Horizon Therapeutics PLC
F:HPR
110.2 EUR
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
HPR, PNEXF

HPR
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
H
Horizon Therapeutics PLC
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
HPR, PNEXF

HPR
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
H
Horizon Therapeutics PLC
F:HPR
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

HPR
75.2%
PNEXF
0%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

Operating Margin

HPR
15.6%
PNEXF
-17 526.7%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

Net Margin

HPR
12%
PNEXF
-21 040%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

FCF Margin

HPR
26.3%
PNEXF
-15 953.3%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

ROE

HPR
8.5%
PNEXF
114.6%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

ROA

HPR
4.8%
PNEXF
-391.1%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

ROIC

HPR
8.2%
PNEXF
3 092.9%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

ROCE

HPR
6.9%
PNEXF
275.4%
LTM 3Y Avg 5Y Avg 10Y Avg
H
Horizon Therapeutics PLC
Pharnext SCA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
HPR, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HPR, PNEXF

Loading
HPR
PNEXF
Difference
www.alphaspread.com

Performance By Year
HPR, PNEXF

Loading
HPR
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare HPR to other stocks
Unlock Full Access to Alpha Spread
Create Free Account